quiz question 4 (lutonix) Flashcards
in the lutonix AV trial, what was the primary patency at 6 months for lutonix?
71.4%
identify the therapeutic drug dose of paclitaxel on the AV lutonix dcb
2 micro grams/ mm^2
what was the reduction in reinterventions at 6 months in the lutonix arm of the lutonix AV trial
31.3%
what was the observed TLPP improvement for lutonix over PTA at 24 months in the lutonix AV trial?
26.9%
In the AV lutonix trial the inclusion criteris for stenosis % was a minimum of what percentage?
50%
the medtronic IN.PACT dcb balloon has ___% more drug on the balloon than Lutonix DCB
75%
data shows slightly significant distal embolic and downstream drug effects from the lutonix 035 formulation at 4x the dose
false
in the AV lutonix trial what % of lesions were restonic
70%
in the AV lutonix dcb trial 30% of patients recieved greater than 25 atm pressure, with the mean pre-dialation pressure of 21.5 atm
true
the average half life of lutonix dcb is ____ hrs compared to ____ hrs for medtronic in-pact dcb
6.9 and 72.5
the av lutonix dcb balloon should be advanced to the lesion within ____ and the balloon should be held for _____
- 30 seconds
- 2-3 minutes
explain why global registry would be used vs. IDE information
global registry data is more “real world data”
the AV lutonix trial consisted of _____ subjects at ____ clinical sites
285 and 23
in the lutonix av trial, what was the average time to first reintervention at 24 months for the lutonix arm
114 days
what % of patients were treated in the forearm radiocephalic in the AV lutonix trial compared to the in.pact ide trial?
33.3 vs. 50.6
in the lutonix AV global registry the TLPP at 180 days for fistula is ____ and the TLPP for the graft is ______
78.1% and 61.9%
